August 5, 2022
Senior TB Project Associate
Treatment Action Group (TAG) is seeking a dynamic, highly motivated, and organized Senior TB Project Associate to support community engagement activities under the SMART4TB Project – a $200 million investment made by USAID to Support, Mobilize, and Accelerate Research for TB Elimination.
August 1, 2022
New Rifapentine Formulations at New Prices: No Excuses for Not Scaling-Up TB Preventive Treatment
Statement / Press
We, the undersigned civil society and community-based organizations, welcome the announcement by Unitaid and its partners that they have reached an agreement with Lupin Limited and Macleods Pharmaceuticals to introduce two formulations of rifapentine at competitive prices.
July 31, 2022
1 / 4 / 6 x 24 Campaign Launched to Rally Energy, Political Will, Funding Needed to Fight Tuberculosis
Statement / Press
Against the backdrop of the COVID-19 pandemic and other concurrent global health, economic, social, and political crises, the 1 / 4 / 6 x 24 Campaign, launched during the AIDS conference in Montreal, seeks to improve TB treatment and prevention worldwide based on the latest medical innovations and to reignite…
July 25, 2022
1 / 4 / 6 x 2024
Webinar / Presentation
Inspired by the legacy of Dr. Paul Farmer, the 1 / 4 / 6 x 24 Campaign calls for the “staff, stuff, space, systems and support” necessary to make groundbreaking short-course TB prevention and treatment regimens accessible to all who need them as a human right by the end of 2024.
July 24, 2022
2022 Pipeline Report
Pipeline Report
Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).
July 18, 2022
TB CAB 10-Year Anniversary Evaluation Report 2011–2021 and Podcast
Publication
In 2021, the Global Tuberculosis Community Advisory Board (TB CAB) celebrated its tenth anniversary of advocating for community engagement in research and improved access to TB prevention, treatment, and diagnostic technologies.
July 8, 2022
Research in Action Awards 2022
On Monday, November 14, 2022 TAG’s 2022 Research in Action Awards (RIAA) will honor some of the best and brightest activists, scientists, and leaders in the fight to end HIV, tuberculosis, and hepatitis C across the U.S. and around the world.
July 1, 2022
Activists Across the World Demand Urgent Action to Improve Access to Lifesaving Tuberculosis (TB) Medicine, Bedaquiline
Statement / Press
A new generic version of bedaquiline produced by Macleods Pharmaceuticals in India has cleared the Global Fund’s Expert Review Panel (ERP), an independent group of experts that reviews finished pharmaceutical products and makes recommendations on their use to the Global Fund.
June 23, 2022
Roundtable on Access to Multi-disease Molecular Diagnostics
Webinar / Presentation
On June 2, 2022, Treatment Action Group (TAG) and Médecins Sans Frontières (MSF) hosted a Roundtable on Access to Multi-disease Molecular Diagnostics, which brought together country program representatives, donors, members of civil society, and other global health actors to: Identify ways to leverage the availability of new multi-disease molecular diagnostic…
June 23, 2022
Treatment Action Group Statement on NYC DOHMH Monkeypox Vaccination Announcement
Statement / Press
In response to this morning’s announcement by the New York City Department of Health and Mental Hygiene (NYC DOHMH) that the DOHMH would open a temporary monkeypox vaccination clinic at the Chelsea Sexual Health Clinic in New York, Treatment Action Group’s Executive Director, Mark Harrington, and TAG HIV Project Director…
June 10, 2022
Government Relations and Policy Associate
Treatment Action Group (TAG) is seeking a talented and motivated candidate to serve as Government Relations and Policy Associate. This dynamic position will manage government relations and advance domestic and global health priorities through outreach and advocacy.
June 10, 2022
Consultancy to Expand Donor Country Fiscal Commitments for Tuberculosis R&D
TAG is seeking a consultant to advance strategic policy advocacy and resource mobilization efforts for TB R&D, specifically for new TB vaccines and by positioning TB within global efforts to curb anti-microbial resistance (AMR).
June 3, 2022
2021 Annual Report
Publication
This year we celebrate the unending dedication and accomplishments of TAG’s staff. They persevered through the challenges of an ongoing pandemic in 2021 to find new ways to carry out our work.
May 17, 2022
Treatment Action Group Mourns Urvashi Vaid, Celebrates Her Life and Legacy
Statement / Press
Treatment Action Group (TAG) today mourns the premature loss of transformative LGBTQ and AIDS activist Urvashi Vaid, formerly executive director of the National Gay and Lesbian Task Force (now the National LGBTQ Task Force) at the height of the U.S. AIDS crisis in the late 1980s and early 1990s, and…
May 16, 2022
U.S. Government Funded Research Brings Shorter Tuberculosis Treatment Regimens to New York City
Statement / Press
We applaud the New York City Department of Health and Mental Hygiene (DoHMH) for its leadership as one of the first TB programs in the U.S. and globally to introduce a new four-month regimen for the treatment of drug-susceptible tuberculosis (TB).